BM
GILD icon

Bill Miller’s Gilead Sciences GILD Stock Holding History

Bill Miller’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-322,955
Closed -$26.2M – 115
2017
Q3 		$26.2M Sell
322,955
-46,705
-13% -$3.57M 1.12% 30
2017
Q2 		$26.2M Sell
369,660
-7,590
-2% -$505K 1.06% 28
2017
Q1 		$25.6M Sell
377,250
-88,800
-19% -$6.24M 1.13% 29
2016
Q4 		$33.4M Sell
466,050
-4,500
-1% -$334K 1.46% 26
2016
Q3 		$37.2M Sell
470,550
-10,000
-2% -$812K 1.52% 24
2016
Q2 		$40.1M Sell
480,550
-43,125
-8% -$3.83M 1.79% 22
2016
Q1 		$48.1M Sell
523,675
-53,900
-9% -$4.86M 1.85% 20
2015
Q4 		$58.4M Buy
577,575
+38,475
+7% +$4M 1.56% 22
2015
Q3 		$52.9M Hold
539,100
– – 1.52% 21
2015
Q2 		$63.1M Hold
539,100
– – 2.19% 20
2015
Q1 		$52.9M Sell
539,100
-149,575
-22% -$15.2M 1.85% 26
2014
Q4 		$64.9M Sell
688,675
-1,600
-0.2% -$165K 2.4% 17
2014
Q3 		$73.5M Buy
690,275
+20,200
+3% +$1.98M 2.94% 6
2014
Q2 		$55.6M Buy
+670,075
New +$52.2M 2.13% 17

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bill Miller's GILD Position: Q4 2017 in Review

Bill Miller sold out of Gilead Sciences (GILD) in Q4 2017, closing a stake of 322,955 shares — an estimated $26.2M sold.

Bill Miller first reported a position in GILD in Q2 2014 and held it in 14 quarters. The position peaked at $73.5M in Q3 2014. 1,575 funds tracked by Wall St. Rank hold GILD as of Q4 2017.

  • Bill Miller reported no remaining Gilead Sciences position as of Q4 2017 after selling out during the quarter.
  • Bill Miller sold 322,955 Gilead Sciences shares in Q4 2017, an estimated $26.2M.
  • Bill Miller first reported a position in Gilead Sciences in Q2 2014 and held it in 14 quarters.
  • Bill Miller's Gilead Sciences position peaked at $73.5M in Q3 2014.
  • 1,575 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2017.

Based on Miller Value Partners's 13F filing for Q4 2017, filed 14 Feb 2018.